BioNTech Announces Fourth Quarter and Full Year 2022 Financial …
Mar 27, 2023 · Fourth Quarter 2022 Oncology Pipeline Update and Outlook. In 2022, BioNTech started five first-in-human clinical trials: BNT116, a FixVac program for non-small cell lung …
BioNTech Announces Third Quarter 2022 Financial Results and …
Nov 7, 2022 · BioNTech invites investors and the general public to join a conference call and webcast with investment analysts on November 7, 2022 at 8.00 a.m. EDT (2.00 p.m. CEST) to …
Pfizer and BioNTech Advance Next-Generation COVID-19 …
Nov 16, 2022 · NEW YORK and MAINZ, GERMANY, NOVEMBER 16, 2022 — Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced that the companies have initiated a …
Pfizer and BioNTech Advance COVID-19 Vaccine Strategy With …
Jul 27, 2022 · Pfizer-BioNTech COVID-19 Vaccine is FDA authorized under Emergency Use Authorization (EUA) for active immunization to prevent coronavirus disease 2019 (COVID-19) …
The Pfizer BioNTech (BNT162b2) COVID-19 vaccine: What you …
Aug 18, 2022 · This article provides a summary of the interim recommendations for the use of the Pfizer BioNTech (BNT162b2) vaccine against COVID-19 issued by WHO Strategic Advisory …
Quarterly Reports - BioNTech
2022. Q4. Q4 and Full Year 2022 Press Release. Q4 and Full Year 2022 Presentation 1.8 MB. Q4 and Full Year 2022 Webcast Recording. Q3. ... BioNTech SE. An der Goldgrube 12. 55131 …
Pfizer and BioNTech Announce New Agreement with U.S.
On June 25, 2022, Pfizer and BioNTech reported pivotal data demonstrating the safety, tolerability and immunogenicity of two Omicron-adapted vaccine candidates. These data have been …
BioNTech Q3 Earnings Review: Good Quarter, Strong Promise
6 days ago · BioNTech earned $21.6bn and $18.5bn of revenues in 2021 and 2022 (splitting revenues 50/50 with Pfizer) and net income, respectively, of $11.7bn, and $10.1bn, as the …
Pfizer and BioNTech Receive U.S. FDA Fast Track Designation for …
Dec 9, 2022 · NEW YORK and MAINZ, GERMANY, DECEMBER 9, 2022 — Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced the companies have received Fast …
BioNTech SE (NASDAQ:BNTX) Q4 2022 Earnings Call Transcript - Yahoo Finance
Mar 30, 2023 · BioNTech SE (NASDAQ: BNTX) Q4 2022 Earnings Call Transcript March 27, 2023. Michael Horowicz: Good morning and afternoon. Thank you for joining us today for …